Abstract | PURPOSE: METHODS: Between January 2009 and July 2011, 28 consecutive patients (18 women; mean age 66 years, range 42-82) underwent protected CAS for symptomatic carotid stenosis following recent PTCA that included bare or drug-eluting stents requiring uninterrupted dual antiplatelet therapy. Primary technical success, neurological complications, major adverse cardiovascular events, and death were evaluated at 30 days and over midterm follow-up. RESULTS: Technical success was 96%; 1 patient suffered a nonfatal major stroke (3.5% 30-day stroke rate) during the procedure. During a median 21.6-month follow-up, 4 (14%) patients died of myocardial infarction (all diabetic smokers with ejection fractions <40%), but there were no new neurological events. Estimated survival was 89.3% at 2 years. Further coronary interventions were performed in 2 diabetic patients with a body mass index >34 kg/m(2). CONCLUSION: This preliminary experience demonstrated that CAS is a reasonable, safe, and effective treatment for patients with symptomatic carotid artery stenosis who were recently treated with coronary stents requiring uninterrupted dual antiplatelet therapy.
|
Authors | Renato Casana, Alison Halliday, Paolo Bianchi, Emanuele Fresa, Vincenzo Silani, Gianfranco Parati, Simonetta Blengino, Lea Cireni, Laura Adobbati, Laura Calvillo, Valerio S Tolva |
Journal | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
(J Endovasc Ther)
Vol. 20
Issue 4
Pg. 546-51
(Aug 2013)
ISSN: 1545-1550 [Electronic] United States |
PMID | 23914865
(Publication Type: Journal Article)
|
Topics |
- Acute Coronary Syndrome
(surgery)
- Adult
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary
- Carotid Stenosis
(surgery)
- Female
- Humans
- Male
- Middle Aged
- Postoperative Complications
(surgery)
- Stents
|